PD Dr. Markus Eckstein

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Institute of Pathology

Re: Assessment of PD-L1, TROP2, and NECTIN-4 Expression in Penile Squamous Cell Carcinoma (2024) Linxweiler J, Klümper N, Mink J, Eckstein M, Junker K Journal article High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma (2024) Klümper N, Cox A, Eckstein M, Kuppe C, Ritter M, Brossart P, Luetkens J, et al. Journal article Bispecific T cell engager therapy for refractory rheumatoid arthritis (2024) Bucci L, Hagen M, Rothe T, Raimondo MG, Fagni F, Tur C, Wirsching A, et al. Journal article Domain generalization across tumor types, laboratories, and species — Insights from the 2022 edition of the Mitosis Domain Generalization Challenge (2024) Aubreville M, Stathonikos N, Donovan TA, Klopfleisch R, Ammeling J, Ganz J, Wilm F, et al. Journal article PITX2 as a Sensitive and Specific Marker of Midgut Neuroendocrine Tumors: Results from a Cohort of 1157 Primary Neuroendocrine Neoplasms (2024) Grass A, Kasajima A, Foersch S, Kriegsmann M, Brobeil A, Schmitt M, Wagner D, et al. Journal article Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer (2024) Zhang S, Yun D, Yang H, Eckstein M, Elbait GD, Zhou Y, Lu Y, et al. Journal article Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma (2024) Hosni S, Kilian V, Kl€umper N, Gabbia D, Sieckmann K, Corvino D, Winkler A, et al. Journal article A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing (2024) Angeloni M, van Doeveren T, Lindner S, Volland P, Schmelmer J, Foersch S, Matek C, et al. Journal article Histomolekulare Klassifikation des Urothelkarzinoms der Harnblase: Vom histologischen Phänotyp zum Genotyp und zurück (2024) Stoll AK, Koll FJ, Eckstein M, Reis H, Flinner N, Wild PJ, Triesch J Journal article Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition (2024) Saal J, Bald T, Eckstein M, Ralser DJ, Brossart P, Ellinger J, Hölzel M, Klümper N Journal article